Final 5-Year Study Results: Dasatinib vs Imatinib in Chronic Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
J. Clin. Oncol 2016 May 23;[EPub Ahead of Print], JE Cortes, G Saglio, HM Kantarjian, M Baccarani, J Mayer, C Boqué, NP Shah, C Chuah, L Casanova, B Bradley-Garelik, G Manos, A HochhausFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.